We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
96 hedge funds and large institutions have $59.6M invested in Invesco Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
3% more funds holding
Funds holding: 93 → 96 (+3)
1.31% less ownership
Funds ownership: 24.13% → 22.82% (-1.3%)
8% less capital invested
Capital invested by funds: $64.9M → $59.6M (-$5.33M)
34% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 29
Holders
96
Holders Change
+3
Holders Change %
+3.23%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
19
Reduced
29
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GS
GWN Securities
Palm Beach Gardens,
Florida
|
+$788K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$643K |
| 3 |
Two Sigma Investments
New York
|
+$409K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$379K |
| 5 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$248K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$5.19M |
| 2 |
Goldman Sachs
New York
|
-$3.51M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$472K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$403K |
| 5 |
CRI
Commonwealth Retirement Investments
Richmond,
Virginia
|
-$401K |
